skip to: page content | site navigation | section menu
Journal of Medical Chemical, Biological and Radiological Defense
J Med CBR Def  |  Volume 3, 2005
Received 15 Jul 2005 |  Accepted 1 Nov 2005  |  Published 23 Dec 2005

Ricin-Induced Tissue Toxicity:  The Role of Oxidative Stress

Zacharias E. Suntres*1, William L. Stone2 , and Milton G. Smith3

1 Medical Sciences Division, Northern Ontario School of Medicine
Lakehead University, Thunder Bay, Ontario, P7B 5E1, Canada

2 College of Medicine, East Tennessee State University
Johnson City, TN 37614-0578, USA

3 Amaox Ltd, Kalamazzo, MI 49079, USA

 

* Corresponding author: Zacharias E Suntres,

PhD Medical Sciences Division

Northern Ontario School of Medicine

955 Oliver Road Lakehead University,

Thunder Bay, Ontario, P7B 5E1, Canada

Tel: 807-766-7395 | Fax: 807-766-7370 | Email: Zacharias.Suntres@NorMed.ca

abstract

Ricin belongs to the type II ribosome inactivating proteins which are heterodimeric glycoproteins that contain a toxophoric A-chain and a lectin B-chain joined together by a disulfide bond. Worldwide, one million tons of castor beans (Ricinus communis) are processed annually in the production of castor oil; the waste mash from this process is five percent ricin by weight.  Ricin has a history of use as a weapon of war, terror, and assassination, it can be prepared as liquid, crystals, or dry powder and it can be disseminated as an aerosol, injected into a victim, or used to contaminate food or water on a small scale.  The toxicity of ricin varies according to the route of administration, but the clinical symptoms frequently are related to a severe inflammatory response and multiorgan failure.  The cytotoxicity of ricin is commonly attributed to the inhibition of protein synthesis consequent to ribosomal damage.  Several studies have also shown that administration of ricin to animals or exposure of cellular systems to ricin result in biochemical, cellular, and functional disturbances consistent with the occurrence of oxidative stress.  The ability of antioxidants to ameliorate ricin-induced biochemical and cellular alterations also implicates oxidative stress as a possible contributing mechanism in ricin toxicity.  In this review, the role of oxidative stress in ricin-induced cytotoxicity will be discussed.

 

INTRODUCTION

Ricin belongs to the type II ribosome inactivating proteins which are heterodimeric glycoproteins that contain a toxophoric A-chain and a lectin B-chain joined together by a disulfide bond   (Endo, 1987a, b; Olsnes, 2004; Stirpe, 2004). The A-chain is transferred across the cell membrane by the B-chain via endocytotic vesicles into cells (Lord, 1998; Sandvig, 2002; Hartley, 2004; Roberts, 2004).  The B chain binds to cell surface carbohydrates containing galactose or N-acetylgalactosamine residue which then allows the A-chain to enter the cell.  Once inside the cell, the A-chain undergoes retrograde transport by receptor-mediated endocytosis, resulting in the toxin being transported through the Golgi complex into the cytosol after the reduction of the disulphide bond.  Once in the cytosol, the A chain exhibits RNA N-glycosidase activity and inactivates ribosomes by enzymatically removing a specific adenine residue from the 28S RNA of the 60S ribosomal subunit.  The adenine residue removed by ricin action is crucial for the binding of elongation factors. A consequence of the ricin-induced depurination is the cessation of protein synthesis (Olsnes, 1972; Endo, 1987a, b; Lord, 1998; Sandvig, 2002; Hartley, 2004; Roberts, 2004).  The clinical latency between exposure and symptoms, ranging between 8 to 24 hours, has been attributed to the transport of the ricin to the interior of the cell.

The exact cause of ricin-induced cell death is unknown but results from several studies have shown that, regardless of the route of administration, ricin A-chain cause organ and tissue lesions that might be the result of vascular disturbances induced by the toxin rather than a direct effect of the toxin itself (Franz, 1997; Howat, 1988).  Clinical trials have shown that administration of ricin A-chain immunotoxin caused vascular syndrome characterized by hypoalbuminemia and edema (Soler-Rodriquez, 1993; Schnell, 2003).  In humans, the estimated lethal dose of ricin is 1 to 10 µg per kg body weight following inhalation or injection (Smallshaw, 2002).    In mice, rats, and primates, high doses of ricin via inhalation produces severe enough pulmonary damage to cause death probably due to hypoxemia resulting from massive pulmonary edema and alveolar flooding (Wilhelmsen, 1996; DaSilva, 2003; Roy, 2003).  In rats, inhaled ricin has an LD50 of 3.7 µg/kg and is associated with pulmonary edema, acute destructive alveolitis and necrosis/apoptosis of the lower respiratory tract epithelium (Gareth, 1995).  Rats treated with ricin at a dose of 10 µg/kg body weight (intravenous administration- iv) showed no alterations in hepatic protein synthesis but treatment adversely affected the sinusoidal cells in the liver consequently resulting in hepatocyte necrosis (Derenzini, 1976).  Intravenous administration of ricin to mice (120 µg/kg body weight) resulted in hemolytic uremic syndrome, including thrombotic microangiopathy, hemolytic anemia, and acute renal failure (Korcheva, 2005; Fu, 2004).  In vitro studies with human umbilical vein endothelial cells showed that ricin damages endothelial cells (Baluna, 2000).  The cytotoxicity of ricin and other ribosome-inactivating proteins are commonly attributed to the inhibition of protein synthesis consequent to ribosomal damage.  A lesser known, but nevertheless important pathophysiologic event in ricin-induced toxicity appears to be oxidative stress (Schulze-Osthoff, 1992; 1993).  Oxidative stress can be defined as a disturbance in the prooxidant-antioxidant balance in favor of the prooxidant, leading to damage.

Oxidative stress can be caused by an elevation in the steady-state concentration of reactive oxygen species (ROS), reactive nitrosative species (RNS) and reactive chlorine species (RCS).  A large number of drugs and other xenobiotics can stimulate the generation of reactive oxygen species by redox cycling (Sies, 1987; Comporti, 1989; Stohs, 1995; Suntres, 2002).  Cellular enzymatic processes, either in the normal metabolic function (electron transport in the mitochondria, microsomes) or disease states (xanthine oxidase in ischemia-reperfusion, cytochrome P-450-dependent activation of xenobiotics) are also responsible for the generation of reactive oxygen species (Sies, 1987; Fang, 2002; Djordjevic, 2004).  Release of reactive oxygen species have also been demonstrated in the respiratory burst of neutrophils and macrophages (Forman and Torres, 2001; Di Virgilio, 2004).  ROS, RNS and RCS indiscriminantly react with any cellular structure (Sies, 1987; Toyokuni, 1999; Forman, 2001; Fang, 2002; Di Virgilio, 2004; Djordjevic, 2004) and regulate a broad array of signal transduction pathways (Forman, 2002; Virgilio, 2004; Djordjevic, 2004).   Several transcription factors such as AP-1, NFkB, MAF, NRL and NF-IL6 are regulated by the intracellular redox state of cells, a status that determines the magnitude of oxidative stress  (Kamata, 1999;  Hsu, 1994; Xanthoudakis, 1994; Kerrpola, 1994; Jang, 2004; Tas, 2005). 

Oxidative stress can also trigger apoptosis or programmed cell death (Forman, 2002; Djordjevic, 2004; Goldenthal, 2004; Kadenbach, 2004). Activated neutrophils responding to inflammatory stimulation produce reactive oxygen species which are known to attack endothelial cells lining the vascular wall and trigger apoptosis. Endothelial cells also produce reactive oxygen species inside the cell that can contribute to oxidative stress and apoptosis, such as during ischemia/reperfusion injury (Djordjevic, 2004; Kadenbach, 2004).  Oxidants can also induce apoptosis by changing cellular redox potentials by altering the reduced glutathione to oxidized glutathione (GSH/ GSSH) as well as by decreasing reducing equivalents, such as NADH and NADPH in the mitochondria (Zoratti, 1995; Bernardi, 1996; Bernardi and Petronilli, 1996).  A change in the redox state, an effect also observed following administration of several toxins, facilitates the formation of permeability transition pores (PT pores), leading to the subsequent release of cytochrome c (Dalton, 1999).  Mitochondrial release of cytochrome c serves as the key regulator of apoptosis because once it is released from the intermembrane space the cell is irreversibly committed to death (Orrenius, 2004).

Maintenance of cell integrity depends on the balance between cellular activation and antioxidant defense systems.  Imbalances may occur due to:  i) increased generation of reactive oxygen species overwhelms the defense system; ii) the defense system is severely compromised and incapable of detoxifying the normal flux or reactive metabolites; and iii) a combination of increased production and decreased detoxication occurs.  The antioxidant defense system consists of enzymatic or non-enzymatic antioxidants. 

The major antioxidant enzymes found in cells are superoxide dismutase, catalase and glutathione peroxidase. Three different types of SOD have been isolated and characterized:  a copper and zinc containing form (Cu-Zn-SOD) that is localized in the cytosol; a manganese-containing SOD (MnSOD) localized in the mitochondria; and, an extracellular form (EC-SOD) in the extracellular matrix.  Catalase, which catalyzes the detoxication of hydrogen peroxide to water and oxygen, is localized mainly in peroxisomes, although some activity has been detected in mitochondria and cell cytoplasm.  Glutathione peroxidase, plays a major role in the detoxication of hydrogen peroxide and other hydroperoxides and lipid peroxides via the glutathione redox cycle (Sies, 1987; Gutteridge, 2000). 

The non-enzymatic antioxidants include vitamin C (ascorbic acid), urate, vitamin E, beta-carotene and other micronutrients such as carotenoids, polyphenols and selenium.  Vitamin E, the principal lipid-soluble antioxidant in the body, is composed of four tocopherols and four tocotrienols and due to its lipophilicity it is present in all cellular membranes (Chow, 2004).  Vitamin E neutralizes the highly reactive singlet oxygen molecules and protects polyunsaturated fatty acids in cell membranes from peroxidation (Buettner, 1993).  Ascorbic acid, a water‑soluble vitamin, is effective in scavenging free radicals, including hydroxyl radical, aqueous peroxyl radicals, and superoxide anion and is considered to be one of the most important antioxidants in extra cellular fluids (Halliwell, 1996; Carr, 1999; Evans, 2001).  Glutathione (GSH) is the most abundant non-protein thiol in living organisms and plays a crucial role in intracellular protection against toxic compounds, such as reactive oxygen species and other free radicals (Anderson, 1997; Anderson, 1998).  It can function as a nucleophile to form conjugates with many xenobiotic compounds and/or their metabolites and can also serve as a reductant in the metabolism of hydrogen peroxide, as well as other organic hydroperoxides.  Also, glutathione is important as a redox buffer (GSH/GSSH) by playing a critical role in the regulation of redox regulated transcription factors (e.g. NFkB) (Schafer, 2001).      

Ricin-Induced Tissue Toxicity.

Ricin is quite stable and extremely toxic to the cells of different organs such as the liver, kidney, lung, pancreas, intestine, and thyroid (Sadani, 1997; Franz, 1997; Greenfield, 2002; DaSilva, 2003).  This toxicity is largely dependent on the route of ricin exposure, an effect most likely attributed to the lectin properties of ricin.  As indicated previously, the chain B of ricin contains lectin which recognizes and binds to galactosides of cell-surface carbohydrates (Sandvig, 2002; Hartley, 2004; Roberts, 2004).  Lectins are being investigated as carrier molecules to target drugs specifically to different cells and tissues including the gastrointestinal tract, lungs, liver, nasal mucosa, buccal cavity and the eye (Bies, 2004).  Inhalation of ricin results in pathologic changes within 8 hours.  Severe respiratory distress and other symptoms are followed by acute hypoxic respiratory failure in 36-72 hours.  Ingestion of ricin results in gastrointestinal hemorrhage, necrosis of the liver, spleen and kidneys; severe localized muscle pain; regional lymph node necrosis, and moderate involvement of visceral organs.  Intravenously administered ricin is found in the spleen followed by kidneys, heart, liver, and thymus (Fodstad, 1976, 1979; Ramsden, 1989; Franz, 1997; Stirpe, 2004; Bismuth, 2004). 

The Role of Oxidative Stress In Ricin Toxicity

Studies have demonstrated that following administration of ricin to animals or exposure of cellular systems to ricin there are biochemical, cellular, and functional disturbances consistent with the occurrence of oxidative stress.  Challenge of mice with ricin has resulted in hepatic lipid peroxidation, glutathione depletion, DNA single strand breaks and increased urinary excretion of carbonyl compounds (Muldoon et al., 1992, 1994; Kumar, 2003).  Increases in kidney lipid peroxidation with concomitant decreases in GSH also occur.  In addition decreases in plasma SOD and increases in catalase activities following exposure of animals to ricin also suggest a significant oxidative stress component (Kumar, 2003).   In another study, it was demonstrated that the enzyme xanthine oxidoreductase was converted from the dehydrogenase to the oxidase form in the liver of ricin-challenged animals (Battelli, 1996).  Xanthine oxidase catalyzes the oxidation of hypoxanthine to xanthine and can further catalyze the oxidation of xanthine to uric acid leading to the production of both superoxide radicals (O2-.) and H2O2.  Also, it has been shown that ricin administration resulted in the destruction of thyroid follicles and a reduction in circulating thyroid hormones.  The effect on the thyroid follicles and circulating hormone are attributed to the production of reactive oxygen species (Sadani, 1997).  Exposure of human cervical cancer cells to ricin resulted in time-dependent increases in intracellular reactive oxygen species production with concomitant reductions in cellular GSH levels and cell viability (Rao, 2005).  Muldoon et al., (Muldoon, 1996) reported that challenge of mice with ricin resulted in dose-dependent increases in macrophage, microsomal, and mitochondrial superoxide anion production. 

The ability of antioxidants to ameliorate ricin-induced biochemical and cellular alterations also implicates oxidative stress as a possible contributing mechanism in ricin toxicity.  In a lethality study based on percentage survival and time to death following a ricin LD100 of 25 µg/kg (ip), vitamin E succinate and butylated hydroxyanisole extended the survival time in response to a lethal dose of ricin (Muldoon and Stohs, 1994).  Challenge of U937 human myeloid leukemia cells with ricin resulted in significant reductions in cellular glutathione levels and the antioxidant N-acetylcysteine strongly inhibited ricin-induced apoptotic cell death in U937 cells, as judged by cytotoxicity, nuclear morphological change, and DNA fragmentation (Oda, 1999).  Abrin, a toxin that belongs to the type II ribosome inactivating proteins and, is similar in structure and properties to ricin, induces cells to generate reactive oxygen species and the antioxidant N-acetylcysteine and 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl can delay abrin-induced cell death (Shih, 2001). 

Sadani and Nadkarni (Sadani, 1994) demonstrated that injection of animals with low doses of ricin (1.5 µg/kg, ip) is specifically toxic to Kupffer cells without affecting the parenchymal cells.  The resistance of the parenchymal cells to ricin was attributed to an elevation in superoxide dismutase, catalase, and glutathione peroxidase levels in the parenchymal cells and the elevation of lipid peroxidation products in the hepatic homogenates originated mainly from damaged kupffer cells.  The observation that Kupfer cells are the first target of ricin, occurring within 4 h after ricin administration, has also been confirmed by other investigators (Skilleter, 1981; Bingen, 1987; Derenzini, 1987; Zenilman, 1988; 1989; Magnusson, 1993).  Activation of macrophages is associated with increased cytokine production, an enhanced oxidative metabolism, and an increased phagocytotic activity.  The high sensitivity of Kupffer cells and other macrophages to ricin has been ascribed to the ability of ricin to bind effectively to the mannose receptors present in these cells via its high-mannose oligosaccharide side chain (Skilleter, 1981; Magnusson, 1993).  It is known that mannose receptors are expressed on the membranes of macrophagic type cells, including mouse peritoneal macrophages, rat Kupffer cells, mouse microglial cells, and rat bone marrow macrophages (Stahl, 1982; Simmons, 1986; Stein, 1992; Magnusson, 1993; Battelli, 2001).

Exposure of macrophages to ricin resulted in a time- and concentration-dependent production of superoxide anion and nitric oxide (Hassoun, 1999), known to form peroxynitrite and nitration of tyrosine residues (Ischiropoulos, 1998).  The role of nitric oxide in the pathogenesis of glomerular thrombotic microangiography has been explored in a ricin-treated rat model (Williams, 2000).   Ricin has shown to cause mucosal inflammation, epithelial damage and increased myoelectric activity (Sjogren, 1994; Stojadinovic, 1997). Korcheva et al. (Korcheva, 2005) showed that ricin induces a severe inflammatory response via stimulation of numerous stress-activated protein kinases and increases in mRNA that encodes for TNF-α and IL-1. 

Pulmonary toxicity was correlated to ricin’s effect on the alveolar macrophages.  This effect was shown to be associated with the transcriptional induction of a number of cell surface inflammatory markers and chemotactic factors (i.e., CD14, ICAM-1, MCP3, and MIP1β) which participate in the recruitment of neutrophils or activation of tissue macrophages; collectively, these disturbances lead to acute lung injury mediated by formation of oxidants and release of proteases (Xu, 1995; Lukacs, 1996; Menten, 2001; DaSilva, 2003).  This is also consistent with findings from other studies where pulmonary exposure to toxins resulted in infiltration and activation of phagocytes in the lung leading to pulmonary injury via the generation of reactive oxygen species.  Antioxidants antagonize the infiltration and activation of activated phagocytes acting in response to the toxins (Suntres, 2002; Suntres, 1996; Suntres, 1998; Cadenas, 2002; Bhattacharyya, 2004). 

In general, macrophages and other phagocytes produce reactive oxygen species during phagocytosis or stimulation with a wide variety of agents through activation of the membrane-associated nicotinamide adenine dinucleotide phosphate reduced (NADPH) oxidase. Once activated, phagocytes infiltrate a site and cause additional damage through the release of neutral proteinase or the generation of superoxide anions (O2-.) via NADPH-oxidase during the respiratory burst.  Superoxide gives rise to hydrogen peroxide spontaneously or via superoxide dismutase.  Production of hypochlorous acid (HOCl) can occur via the interaction with myeloperoxidase. On stimulation and phagocytosis, HOCl production by the neutrophil accounts for up to 70% of the oxygen consumed, making it the major oxidative product of neutrophils (Klebanoff, 1991). HOCl reacts readily with thiols and thioethers, Fe-S centers, and nucleotides (Alison, 1976; Winterbourn , 1985; Folkes, 1995), with amines to form reactive chloramines (Thomas, 1983), and with unsaturated fatty acids to form chlorohydrins (Winterbourn, 1992).  Excessive production of reactive oxygen species, in addition to their direct toxic actions, will also exacerbate the inflammatory process, cause further tissue damage, and drive redox-regulated gene expression.  

One of the mechanisms by which ricin may initiate oxidative stress-induced cellular injury is linked to the production of tumor necrosis factor-alpha (TNF-α), which is coded for by the transcription factor NFkB.  TNF-α is produced mainly by activated macrophages and in smaller amounts by other cell types (Vandenabeele, 1995; Bradham, 1998).  Kupffer cells, the resident hepatic macrophages, are a rich source of cytokines in the liver (Boulton, 1997; Gregory, 1998) and as discussed previously, numerous studies have shown that Kupffer cells are the first target of ricin, occurring within 4 h after ricin administration (Skilleter, 1981; Magnuson, 1993).  Furthermore, pretreatment of mice with anti-TNF-α antibody 2 h prior to ricin administration significantly reduced the urinary excretion of by-products of oxidative stress such as malondialdehyde, formaldehyde, and acetone and decreased hepatic lipid peroxidation and DNA single strand breaks (Muldoon et al., 1994). Results from other studies have also confirmed the role of TNF-α in ricin toxicity as evidenced by the findings where exposure of the macrophage J744A.1 cells to ricin resulted in TNF-α release and TNF-α antibody antagonized the cytotoxic effects of ricin (Hassoun, 2000).  Ricin induced the release of TNF-α and interleukin-1 beta by human peripheral-blood mononuclear cells in a dose- and time-dependent manner (Licastro, 1993).  More recently, it was reported that ricin induced the expression of mRNAs for TNF-α in the Caco-2 cell line, which is derived from a human colon carcinoma and has characteristics that closely resemble intestinal epithelial cells (Yamasaki, 2004).   Exposure of RAW 264.7 cells to ricin strongly induced the activation of the JNK and p38 MAPK and produced a dose-dependent increase in TNF-α mRNA and TNF-α (Korcheva, 2005).  Among the other protein synthesis inhibitors examined in another study, modeccin and anisomyxcin, known to trigger a ribotoxic stress response similar to ricin, also induced the release of TNF-α (Higuchi, 2003; Yamasaki, 2004). 

It is well established that TNF-α regulates the inflammatory processes through the induction of genes that code for several immune mediators including interleukin (IL)-1, IL-6, IL-8, macrophage inflammatory protein (MIP)-2, granulocyte-macrophage colony-stimulating factor, intracellular adhesion molecule-1, endothelial leukocyte adhesion molecule-1.  These mediators are known to enhance vascular permeability, stimulate the expression of adhesion molecules on endothelial cells, and serve as leukocyte chemoattractants (chemokines).  The expression of mRNAs for IL-8, monocyte chemoattractant protein, macrophage inflammatory protein (MIP)-1α and MIP-1β was also observed in the ricin-challenged Caco-2 cell line (Yamasaki, 2004).   Similarly, the enhanced transcriptions of macrophage colony stimulating factor-1, CD14, monocyte chemoattractant protein-3, macrophage inflammatory protein-1β and intercellular adhesion molecule-1 were also observed in the lungs of ricin-exposed animals (DaSilva, 2003).  In the same study, it was also demonstrated that ricin activated the nuclear factor (NF)-kappa B/rel family of transcription factors (nuclear factor of kappa light chain protein enhancer in B-cells inhibitor alpha (NFKBIA), I-kappa B, tumor necrosis factor alpha-induced protein (tnfaip)-3) as well as a number of inflammatory mediators, including IL-6, serine protease inhibitor 2.2, and interferon regulatory factor-1.  The findings from these studies possibly suggest that the sustained phagocytic activity and transendothelial trafficking of immune cells into the damaged lungs of ricin-challenged animals are mediated through TNF-α-regulated processes.

Various effects of TNF-α are mediated by the induction of a cellular state consistent with oxidative stress.  Reactive oxygen species have been implicated in the signaling pathways initiated by TNF-α and these ROS may also function as second messengers for TNF-α mediated signaling (Hennet, 1993; Schulze-Osthoff, 1998). Exogenously added reactive oxygen species to cells reproduces many of the toxic actions of TNF-α.  Cells treated with certain antioxidants or kept under anaerobic conditions were less susceptible to TNF-α-induced cytotoxicity (Schulze-Osthoff, 1992).  Furthermore, ROS are critical in the regulation of transcription factors in the AP-1 and NF-κB families which have crucial functions in proliferation, differentiation, and morphogenesis and have been shown to be activated also in the absence of protein synthesis (Buscher, 1988; Devary, 1993). 

Other studies have demonstrated that the mitochondrial electron transport system plays a key role in inducing TNF-α cytotoxicity, presumably by the formation of reactive oxygen species (Hennet, 1993; Schulze-Osthoff, 1998; Moreno-Manzano, 2000). Antimycin A, a mitochondrial inhibitor that increases the generation of reactive oxygen species, potentiates the TNF-α-triggered NF-κB activation while depletion of the mitochondrial oxidative metabolism resulted in resistance towards TNF-α cytotoxicity, as well as in inhibition of NF-κB activation by TNF-α (Schulze-Osthoff, 1993).  It has been proposed that the apoptosis-inducing activity of abrin, a type II ribosomal inhibiting protein, could be due to a decrease in the levels of anti-apoptotic factors like Bcl-2 and oxidative stress due to mitochondrial damage leading to increased reactive oxygen production (Narayanan, 2004).

The mitochondrial pathway of apoptosis due to depletion of the intracellular NAD+ pool is known to be a result of PARP [poly(ADP-ribose) polymerase] activation.  Moderate activation of PARP facilitates the efficient repair of DNA damage induced by several stimuli, such as reactive oxygen species or ionizing radiation.   Severe genotoxic stress leads to rapid energy consumption and subsequently cell death.  It has been shown that ricin is capable of inducing depletion of intracellular NAD+ and ATP levels, following PARP activation in U937 cells (Komatsu, 2000) resulting in apoptotic cell death.  Another mechanism by which ricin may induce apoptotic cell death has centered on its ability to increase caspase -3-, caspase-6- and caspase-9- activities in human leukemia U937 cells (Villa, 1997; Komatsu, 1998; Tamura, 2002).  Caspases are cysteinyl aspartate-specific proteases that play a crucial role in the apoptotic signal pathway, they are sensitive to the redox status of the cell, and their activity is blocked by excessive oxidative stress (Hampton, 1998).  Komatsu et al., (Komatsu, 1998) have reported that a broad inhibitor of the caspase family proteases (Z-Asp-Ch2-DCB) and the specific serine protease inhibitor, dichloroisocoumarin, blocked ricin-induced apoptosis in human leukemia U937 cells.  Furthermore, it was demonstrated that ricin-induced apoptosis of U937 cells (Oda, 1999) or human cervical cancer cells (Rao, 2005) was associated with glutathione depletion.  Although the exact role of glutathione depletion in apoptosis is unclear, selective depletion of reduced glutathione in mitochondria increase reactive oxygen cell accumulation and sensitizes cells to the apoptotic effects of TNF-α (Fernandez-Checa, 1998; Pierce, 2000). 

Presently, the underlying mechanism(s) responsible for the release of TNF-α by ricin are not well understood.  Higuchi et al., (Higuchi, 2004) have shown that treatment of RAW264.7 cells with ricin resulted in the induction of TNF-α , with the maximum levels of TNF-α secretion being attained at a ricin concentration that caused only partial inhibition of protein synthesis.  Results from a limited number of studies examining the effect of different protein synthesis inhibitors on the induction of TNF-α release, suggested that ricin and anisomycin, which commonly act on 28rRNA and resulting  in a ribotoxic stress response, may trigger the multiple signal transduction pathways through the activation of the stress-activated protein kinases (SAPKs), N-terminal-c-Jun-kinases (JNK), and p38 MAP kinase (Korcheva, 2005; Laskin, 2002; Iordanov, 1997). A major question remains as to the precise linkage between ribosomal RNA damage and induction of MAP kinase signaling cascades (Iordanov, 1997; Iordanov, 1998; Laskin, 2002).   It is becoming clear that the ribotoxic stress pathway is a highly specific event and ribotoxic stressors appear to be restricted to those toxicants that interact with or damage the R/S loop near the 3-end of the 28S rRNA including ricin, anisomycin, palytoxin, and ultraviolet light radiation (Iordanov, 1997; 1998; Laskin, 2002).  More recently, it was shown that the IL-8 inducing activity in ricin-challenged Caco-2 cells correlates with the RNA N-glycosidase activity and not with general protein synthesis and among the RNA N-glycosidases tested , the members of the Shiga toxin are the strongest inducers of IL-8 production in Caco-2 cells (Yamasaki, 2004). 

Management of Ricin-Intoxication. 

Management of ricin-intoxicated patients depends on the route of exposure. Patients with pulmonary intoxication are managed by supportive treatment for pulmonary edema. Gastrointestinal intoxication is best managed by vigorous gastric decontamination with superactivated charcoal, followed by use of cathartics such as magnesium citrate. Volume replacement of GI fluid losses is important. In percutaneous exposures, treatment would be primarily supportive (Franz, 1997). 

The cell responds to ricin toxicity by activating its defensive mechanisms such as evoking inflammatory processes, altering protein trafficking, cell differentiation and turning on apoptotic signals (Day, 2001; Elson, 2001; Hu, 2001).

Very little is known of the role that these or any other gene regulatory paths may play in the intoxication process initiated by ricin. However, the knowledge of such complex paths is critical for the development of effective prophylactic and therapeutic countermeasures to ricin.  So far, it has been shown that the ricin induced expression of TNF-α protein in RAW 264.7 macrophages was reduced significantly following the specific inhibition of JNJ, p38 MAPK, and ERK1/2 kinases known to regulate the expression of mRNAs that encode inflammatory cytokines and chemokines.     In another study, the ricin-induced cytotoxicity in macrophage J744A.1 cells was antagonized by pretreatment with a TNF-α -antibody (Hassoun, 2000).  The unregulated release of TNF-α into the circulation results in circulatory dysfunction, increased endothelial permeability and inflammation of different organs. 

Antioxidant supplementation may prove to be beneficial in decreasing the oxidative stress in animals and cellular systems exposed to ricin.  Several studies have shown that TNF-α induces O2-. formation in mitochondria which dismutates to H2O2 by the superoxide dismutase (Mn SOD).  H2O2 can easily cross the mitochondrial membrane and be released into the cytosol where it could induce stimulate mitogen-activated protein kinases, such as ERK1/2, p38 and JNK, and the transcription factor, nuclear factor-kappaB, known to induce the expression of mRNA of a variety of pro-inflammatory mediators including TNF-α, interleukins, adhesion molecules and enzymes, such as cyclooxygenase (COX-2) and iNOS.  These pro-inflammatory mediators are implicated in the pathogenesis of several acute inflammatory disorders.  Also, TNF-α released during inflammation transiently activates neutrophils and macrophages, thereby causing them to release O2-. as a consequence of the activation of membrane-associated NADPH oxidase (Klebanoff, 1986).  Besides NADPH oxidase, another superoxide-generating enzyme thought to be induced after ricin exposure is xanthine oxidase (XO). 

It is evident that antioxidants can protect both extracellularly by scavenging toxic ROS and intracellularly by interrupting lipid peroxidation within the membrane. Also, they can interfere early in inflammatory responses by blocking or modifying the signal transduction of inflammatory cytokines and ricin, thereby modulating cellular activation.  Administration of vitamin E succinate and butylated hydroxyanisole extended the survival time in rats challenged with a lethal dose of ricin (Muldoon, 1994)  The antioxidant N-acetylcysteine (NAC) strongly inhibited the ricin-induced apoptotic cell death in U937 cells (Oda, 1999).  Vitamin E and NAC as well as other antioxidants are known to inhibit mitogen-activated protein kinases, such as ERK1/2, p38 and JNK, and the transcription factor NF-κB (Kyaw, 2004; Zafarullah, 2003; Cadenas, 2002).  Antioxidants do not exert an indiscriminate stimulating effect on the immune cell function, are effective and safe in a large range of concentrations.

Summary.

The cytotoxicity of ricin is commonly attributed to the inhibition of protein synthesis in ribosomes.  To-date there are no effective prophylactic and therapeutic countermeasures to ricin and management of ricin intoxication remains supportive.  More recent studies provide evidence that ricin can also mediate its toxic effects via oxidative stress-mediated mechanisms resulting to apoptosis and cell death.  Ricin has been shown to selectively activate phagocytes, known to generate excessive amounts of reactive oxygen species, which in addition to their direct toxic actions, also exacerbate the inflammatory process and cause further tissue damage.  The reduction of inflammation has been suggested as a viable drug target for the toxic pulmonary effects of ricin. 

Presently, inflammatory mediators and other gene regulatory circuits are being investigated in order to assess the role they may play in the intoxication process initiated by ricin. The knowledge of such complex paths and their manipulation is critical for the development of effective prophylactic and therapeutic countermeasures to ricin.  Certainly, antioxidant supplementation may prove to be beneficial in decreasing the oxidative stress in animals and cellular systems exposed to ricin. 

 

references

Allison, W. S. (1976)  Formation and reactions of sulfenic acids in proteins. Acc. Chem. Res. 9, 293-299.

Anderson, M.E. (1997) Glutathione and glutathione delivery compounds. Adv. Pharmacol. 38, 65-78.

Anderson, M.E.; Luo, J.L. (1998)  Glutathione therapy: from prodrugs to genes.Semin. Liver Dis. 18, 415-424.

Baluna, R.; Coleman, E.; Jones, C.; Ghetie, V.; Vitetta, E.S. (2000) The effect of a monoclonal antibody coupled to ricin A chain-derived peptides on endothelial cells in vitro: insights into toxin-mediated vascular damage.  Exp Cell Res. 258, 417-424.

Battelli, M.G.; Buonamici, L.; Polito, L.; Bolognesi, A.; Stirpe, F. (1996)  Hepatotoxicity of ricin, saporin or a saporin immunotoxin:  xanthine oxidase activity in rat liver and blood serum.  Virchows Arch 427, 529-535.

Battelli, M.G.; Muisiani, S.; Monti, B.; Buonamici, L.; Sparapani, M.; Contestabile, A.; Stirpe, F.  (2001).  Ricin toxicity to microglial and monocytic cells.  Neurochem International 39, 83-93.

Bauer V.; Bauer F.  (1999)  Reactive oxygen species as mediators of tissue protection and injury.  Gen Physiol Biophys.18, 7-14.
Bernardi, P. (1996) The permeability transition pore. Control points of a cyclosporin A-sensitive mitochondrial channel involved in cell death. Biochem. Biophys. Acta 1275, 5-9. 
Bernardi, P.; Petronilli, V.  (1996) The permeability transition pore as a mitochondrial calcium release channel: a critical appraisal. J. Bioenerg Biomembr. 28, 129-136.

Bhattacharyya, J.; Biswas, S.; Datta, A.G.  (2004)  Mode of action of endotoxin: role of free radicals and antioxidants.  Curr Med Chem. 11, 359-368.

Bies, C.; Lehr, C-M.; Woodley, J.F. (2004)  Lectin-mediated drug targeting:  history and applications.  Adv Drug Deliv Rev 56:425-435.

Bingen, A.; Creppy, E.E.; Gut, J.P.; Dirheimer, G.; Kirn, A. (1987) The Kupffer cell is the first target in ricin-induced hepatitis.  J Submicrosc Cytol. 19, 247-256.

Bismuth, C.; Borron, S.W.; Baud, F.J.; Barriot, P.  (2004)  Chemical weapons:  documented use and compounds on the horizon.  Toxicol. Lett. 149, 11-18.

Boulton,R.; Woodman,A.; Calnan,D.; Selden,C.; Tam,F.; Hodgson,H. (1997) Nonparenchymal cells from regenerating rat liver generate interleukin-1 alpha and -1 beta: a mechanism of negative regulation of hepatocyte proliferation. Hepatology, 26, 49–58.

Bradham,C.A.; Plümpe,J.; Manns,M.P.; Brenner,D.A.; Trautwein,C. (1998) Mechanisms of hepatic toxicity. I. TNF-induced liver injury. Am. J. Phys., 275, G387–G392.

Buettner, G.R.  (1993)   The pecking order of free radicals and antioxidants: lipid peroxidation, alpha-tocopherol, and ascorbate.  Arch Biochem Biophys. 300, 535-543.

Buscher, M.; Rahmsdorf, H.J.; Litfin, M.; Karin, M.; Herrlich, P. (1988)  Activation of the c-fos gene by UV and phorbol ester:  different signal transduction pathways converge to the same enhancer element.  Oncogene 3, 301-311.

Cadenas, S.; Cadenas, A.M. (2002)  Fighting the stranger-antioxidant protection against endotoxin toxicity.  Toxicol.  180, 45-63.

Carr, A.; Frei, B.  (1999) Does vitamin C act as a pro-oxidant under physiological conditions?  FASEB  J. 13, 1007-1024.

Chow, C.K.  (2004)  Biological functions and metabolic fate of vitamin E revisited.  J Biomed Sci. 11, 295-302.

Dalton, T. P.; Shertzer, H.G.; Puga, A (1999).  Regulation of gene expression by reactive oxygen. Annu Rev Pharmacol Toxicol, 39, 67-101.

DaSilva, L.; Cote, D.; Roy, C.; Martinez, M.; Duniho, S.; Pitt, M.L.; Downey, T.; Dertzbaugh, M. (2003)  Pulmonary gene expression profiling of inhaled ricin.  Toxicon. 41, 813-822.

Day, P.J.; Owens, S.R.; Wesche, J.; Olsnes, S.; Roberts, L.M.; Lord, J.M., (2001). An interaction between ricin and calreticulin that may have implications for toxin trafficking. J. Biol. Chem. 276, 7202–7208.

Devary, Y.; Rosette, C.; DiDonato, J.A.; Karin, A. (1993)  NF-kappa B activation by ultraviolet light not dependent on a nuclear signal.  Science 261, 1442-1445.

Di Virgilio, F. (2004)  New pathways for reactive oxygen species generation in inflammation and potential novel pharmacological targets.  Curr Pharm Des.10, 1647-1652.

Djordjevic, V.B. (2004)  Free radicals in cell biology.  Int Rev Cytol. 237:57-89.

Elson, D.A.; Thurston, G.; Huang, L.E.; Ginzinger, D.G.; McDonald, D.M.; Johnson, R.S.; Arbeit, J.M., (2001). Induction of hypervascularity without leakage or inflammation in transgenic mice overexpressing hypoxia-inducible factor-1 alpha. Genes Dev. 15, 2520–2532.

Endo, Y.; Tsurugi, K. (1987a). RNA N-glycosidase activity of ricin A-chain. Mechanism of action of the toxic lectin ricin on eukaryotic ribosomes. J. Biol. Chem. 262, 8128–8130.

Endo, Y.; Mitsui, K.; Motizuki, M.; Tsurugi, K. (1987b). The mechanism of action of ricin and related toxic lectins on eukaryotic ribosomes. The site and the characteristics of the modification in 28 S ribosomal RNA caused by the toxins. J. Biol. Chem. 262, 5908–5912.

Evans, P.; Halliwell, B. (2001)  Micronutrients: oxidant/antioxidant status. Br. J. Nutr. 85, S67-S74

Fang, Y.Z.; Yang, S.; Wu, G. (2002) Free radicals, antioxidants, and nutrition.  Nutrition. 18, 872-879.

Folkes, L. K; Candeias, L.P.; Wardman, P.  (1995)  Kinetics and mechanisms of hypochlorous acid reactions. Arch. Biochem. Biophys. 323, 120-126. 

Fu, X.J.; Iijima, K.; Nozu, K.; Hamahira, K.; Tanaka, R.; Oda, T.; Yoshikawa, N.; Matsuo, M.  (2004)  Role of p38 MAP kinase pathway in a toxin-induced model of hemolytic uremic syndrome.  Pediatr. Nephrol. 19, 844-852.

Gareth, D.; Griffiths, G.D.; Rice, P.; Allenby, A.C.; Bailey, S.C.; Upshall, D.G., (1995).  Inhalation toxicology and histopathology of ricin and abrin toxins. Inhal. Toxicol. 7, 269–288.

Halliwell, B. (1996) Vitamin C: antioxidant or pro-oxidant in vivo?  Free Rad. Res. 25, 439-454.

Hartley, M.R.; Lord, J.M.  (2004)  Cytotoxic ribosome-inactivating lectins from plants.  Biochem. Biophys. Acta 1701, 1-14.

Hennet, T.; Richter, C.; Peterhans, E. (1993) Tumour necrosis factor-alpha induces superoxide anion generation in mitochondria of L929 cells.  Biochem J. 289, 587-592.

Fernandez-Checa, J.C.; Kaplowitz, N.; Garcia-Ruiz, C.; Colell, A.  (1998)  Mitochondrial glutathione:importance and transport.  Semin Liver Dis. 18, 389-401.

Franz, D.R.; Jaax, N.K. (1997) Ricin Toxin.  In:  Medical Aspects of Chemical and Biological Warfare.  Borden Institute, Walter Reed Army Medical Center, Washington, DC, Chapter 32, pp. 631-642.

Fodstad, O.; Olsnes, S.; Pihl, A.  (1976) Toxicity, distribution and elimination of the cancerostatic lectins abrin and ricin after parenteral injection into mice.  Br J Cancer 34, 418-425.

Fodstad, O.; Johannessen J.V.; Schjerven, L.; Pihl, A. (1979) Toxicity of abrin and ricin in mice and dogs.  J Toxicol Environm Health 5, 1073-1084.

Forman, H.J.; Torres, M. (2001) Redox signaling in macrophages. Mol Aspects Med.22, 189-216.

Forman, H.J.; Torres, M. (2002).  Reactive oxygen species and cell signaling.  Respiratory burst in macrophage signaling.  Am J Respir Crit Care Med 166, S4-S7.

Goldenthal, M.J.; Marin-Garcia,  J. (2004) Mitochondrial signaling pathways: a receiver/integrator organelle.  Mol Cell Biochem. 262, 1-16.

Greenfield, R.A.; Brown, B.R.; Hutchins, J.B.; Iandolo, J.J.; Jackson, R.; Slater, L.N.; Bronze, M.S.  (2002).  Microbiological, biological, and chemical weapons of warfare and terrorism.  Am J Med Sci 323, 326-340.

Gregory,S.; Wing,E.; Danowski,K.; van Rooijen,N.; Dyer,K.; Tweardy,D. (1998) IL-6 produced by Kupffer cells induces STAT protein activation in hepatocytes early during the course of systemic listerial infections. J. Immunol. 160, 6056–6061.

Gutteridge, J.M.; Halliwell, B.  (2000) Free radicals and antioxidants in the year 2000.  A historical look to the future.  Ann N Y Acad Sci. 899:136-147.

Hampton, M. B.; Orrenius S.  (1998). "Redox regulation of apoptotic cell death in the immune system." Toxicol Lett 102-103: 355-358.

Hassoun, E.A.; Wang, X.  (1999)  Time-and concentration-dependent production of superoxide anion, nitric oxide, DNA damage and cellular death by ricin in the J774A.1 macrophage cells.  J Biochem Mol Toxicol 13, 179-185.

Hassoun, E.; Wang, X.  (2000)  Ricin-induced toxicity in the macrophage J744A.1 cells:  the role of TNF-α and the modulation effects of TNF-α polyclonal antibody.  J Biochem MolToxicol 14, 95-101.

Higuchi, S.; Tamura, T.; Oda, T.  (2003)  Cross-talk between the pathways leading to the induction of apoptosis and the secretion of tumor necrosis factor-alpha in ricin-treated RAW 264.7 cells.  J Biochem (Tokyo) 134, 927-933.

Howat, A.J. (1988)  The toxic plant proteins ricin and abrin induce apoptotic changes in mammalian lymphoid tissues and intestine.  J Pathol 154, 29-33.

Hsu, W.; Kerppola, T.K.; Chen, P.L.; Curran, T.; Chen-Kiang, S.  1994)  Fos and Jun repress transcription activation by NF-IL6 through association at the basic zipper region.  Mol Cell Biol 14: 268-276.         

Hu, R.; Zhai, Q.; Liu, W.; Liu, X. (2001). An insight into the mechanisms of cytotoxicity of ricin to hepatoma cell: roles of bcl-2 family proteins, caspases, Ca(2+)-dependent proteases and protein kinase C. J. Cell. Biochem. 81, 583–593.

Iordanov, M.S.; Pribnow, D.; Magun, J.L.; Dinh, T.H.; Pearson, J.A.; Chen, S.L.; Magun, B.E. (1997)  Ribotoxic stress response:  Activation of the stress-activated protein kinase JNK1 by inhibitors of the peptidyl transferase reaction and by sequence-specific RNA damage to the α-sarcin/ricin loop in the 28S rRNA.  Mol Cell Biol 17, 3373-3381.

Iordanov, M.S.; Magun, B.E.  (1999)  Different mechanisms of c-Jun NH(2)-terminal kinase-1 (JNK1) activation by ultraviolet-B radiation and by oxidativestressors.  J Biol Chem 274, 25801-25806.

Ischiropoulos, H. (1998)  Biological tyrosine nitration:  a pathophysiological function of nitric oxide and reactive oxygen species.  Arch. Biochem. Biophys. 356:1-11.

Jang, J. H.; Surh, Y.J.  (2004). "Bcl-2 attenuation of oxidative cell death is associated with up-regulation of gamma-glutamylcysteine ligase via constitutive NF-kappaB activation." J Biol Chem 279: 38779-38786.

Kadenbach, B.; Arnold, S.; Lee, I.; Huttemann, M.  The possible role of cytochrome c oxidase in stress-induced apoptosis and degenerative diseases.  Biochem Biophys Acta 1655:400-408.

Kamata, R.; Hirata, H.  (1999) Redox regulation of cellular signalling.  Cell Signal. 11:1-14.

Kerppola, T.K.; Curran, T. (1994). A conserved region adjacent to the basic domain is required for recognition of an extended DNA binding site by Maf/Nrl family proteins. Oncogene 9: 3149-318.     

Klebanoff, S.J.; Vadas, M.A.; Harlan, J.M.; Sparks, L.H.; Gamble, J.R.; Agosti, J.M.; Waltersdorph, A.M.  (1986)  Stimulation of neutrophils by tumor necrosis factor. J. Immunol. 136, 4220–4225.

Klebanoff, S. J. (1991)  Myeloperoxidase: occurrence and biological function. In: J. Everse, K. E. Everse, and M. B. Grisham(eds) Peroxidases in Chemistry and Biology, Boca Raton, FL: CRC, p. 1-35.

Komatsu, N.; Oda, T.; Muramatsu, T. (1998) Involvement of both caspase-like proteases and serine proteases in apoptotic cell death induced by ricin, modeccin, diphtheria toxin, and Pseudomonas toxin.  J. Biochem 124, 1038-1044.

Korcheva, V.; Wong, J.; Corless, C.; Iordanov, M.; Magun, B.  (2005)  Administration of ricin induces a severe inflammatory response via nonredundant stimulation of ERK, JNK, and p38 MAPK and provides a mouse model of hemolytic uremic syndrome.  Am. J. Pathol. 166, 323-339.

Kroemer, G. P.; Petit, N.; Zamzami, J.; Vayssiere, L.; Mignotte, B. (1995) The biochemistry of programmed cell death. FASEB J. 9, 1277-1287.

Kumar, O.; Sugendran, K.; Vijayaraghavan, R. (2003)  Oxidative stress associated hepatic and renal toxicity induced by ricin in mice.  Toxicon. 41, 333-338.

Kyaw,M.; Yoshizumi, M.; Tsuchiya, K.; Izawa, Y.; Kanematsu, Y.; Tamaki, T.  (2004)  Atheroprotective effects of antioxidants through inhibition of mitogen-activated protein kinases.  Acta Pharmacol Sin. 25, 977-985.

Laskin, J.D.; Heck, D.E.; Laskin, D.L.  (2002)  The ribotoxic stress response as a potential mechanism for MAP kinase activation in xenobiotic toxicity.  Toxicol Sci. 69, 289-291.

Licastro, F.; Morini, M.C.; Bolognesi, A.; Stirpe,  F.  (1993)  Ricin induces the production of tumour necrosis factor-alpha and interleukin-1 beta by human peripheral-blood mononuclear cells. Biochem J. 294 ( Pt 2), 517-520.

Lord, J.M.; Roberts, L.M. (1998).  Toxin entry:  retrograde transport through the secretory pathway.  J Cell Biol 140, 733-736.

Lukacs, N.W.; Ward, P.A. (1996). Inflammatory mediators, cytokines, and adhesion molecules in pulmonary inflammatory and injury. Adv. Immunol. 62, 257–305.

Magnusson, S.; Berg, T. (1993)  Endocytosis of ricin by rat liver cells in vivo and in vitro is mainly mediated by mannose receptors on sinusoidal endothelial cells.  Biochem J. 291, 749-755.

McKeon, T.A.; Chen, G.Q.; Lin, J.-T.  (2000)  Biochemical aspects of castor oil biosynthesis.  Biochem. Society Transact. 28, 972-974.

Menten, P.; Wuyts, A.; Van Damme, J. (2001). Monocyte chemoattractant protein-3 Eur. Cytokine Netw. 12, 554–560.

Moreno-Manzano, V.; Ishikawa, Y.; Lucio-Cazana, J.; Kitamura, M.  (2000)  Selective Involvement of Superoxide Anion, but Not Downstream Compounds Hydrogen Peroxide and Peroxynitrite, in Tumor Necrosis Factor-α-induced Apoptosis of Rat Mesangial Cells.  J Biol Chem, 275, 12684-12691.

Muldoon, D.F.; Hassoun, E.A.; Stohs, S.J. (1992)  Ricin-induced hepatic lipid peroxidation, glutathione depletion, and DNA single-strand breaks in mice.  Toxicon. 30, 977-984.

Muldoon, D.F.; Bagchi, D.; Hassoun, E.A.; Stohs, S.J.  (1994)  The modulating effects of tumor necrosis factor alpha antibody on ricin-induced oxidative stress in mice.  J Biochem Toxicol. 9, 311-318.

Muldoon, D.F.; Stohs, S.J. (1994)  Modulation of ricin toxicity in mice by biologically active substances.  J Appl Toxicol 14, 81-86.

Narayanan, S.; Surolia, A.; Karande, A.A. (2004)  Ribosome-inactivating protein and apoptosis:  abrin causes cell death via mitochondrial pathway in Jurkat cells.  Biochem. J. 377, 233-240.

Oda, T.; Iwaoka, J.; Komatsu, N.; Muramatsu, T.  (1999)  Involvement of N-acetylcysteine-sensitive pathways in ricin-induced apoptotic cell death in U937 cells.  Biosci. Biotechnol. Biochem. 63, 341-348.

Olsnes, S; Pihl, A.  (1972)  Ricin-a potent inhibitor of protein synthesis.  FEBS Lett. 20, 327-329.

Olsnes, S. (2004)  The history of ricin, abrin  and related toxins.  Toxicon 44, 361-370.

Orrenius, S. (2004)  Mitochondrial regulation of apoptotic cell death.  Toxicol Lett. 149:19-23.

Pierce, R.H.; Cambnell, J.S.; Stephenson, A.B.; Franklin, C.C.; Chaisson, M.; Poot, M.; Kavanagh, T.J.; Rabinovitch, P.S.; Fausto, N.  (2000)  Disruption of redox homeostatsis in tumour necrosis-factor-induced apoptosis in a murine hepatocyte cell line.  Am. J. Pathol. 157:221-236.

Ramsden, C.S.; Drayson, M.T.; Bell, E.B. (1989) The toxicity, distribution and excretion of ricin holotoxin in rats.  Toxicol. 55, 161-171.

Rao, L.P.V.; Jayaraj, R.; Bhaskar, A.S.B.; Kumar, O.; Bhattacharya, R.; Saxena, P.; Dash, P.K.; Vijayaraghavan.  (2005)  Mechanism of ricin-induced apoptosis in human cervical cancer cells.  Biochem. Pharmacol. 69, 855-865.

Roberts, L.M.; Smith D.C. (2004)  Ricin:  the endoplasmic reticulum connection.  Toxicon 44, 469-472.

Roy, C.J.; Hale, M.; Hartings, J.M.; Pitt, L.; Duniho, S.  (2003)  Impact of inhalation exposure modality and particle size on the respiratory deposition of ricin in BALB/c mice.  Inhal Toxicol. 5, 619-638.

Sadani, G.; Nadkarni, G.D. (1994)  Role of antioxidant enzyme defence in sparing rat hepatocytes from toxicity of ricin at low dose.  Indian J Exp Biol 32, 354-355.

Sadani, G.R.; Soman, C.S.; Deodhar, K.K.; Nadkarni, G.D. (1997)  Reactive oxygen species involvement in ricin-induced thyroid toxicity in rat.  Hum Exp Toxicol 16, 254-256.

Saini, K. S.; N. I. Walker. (1998) Biochemical and molecular mechanisms regulating apoptosis. Mol. Cell. Biochem. 178, 9-25.

Sandvig, K.; Van Deurs, B. (2002)  Transport of protein toxins into cells:  pathways used by ricin, cholera toxin and Shiga toxin.  FEBS Lett. 529, 49-53.

Schafer, F.Q.; Buettner, G.R.  (2001)  Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple.  Free Radic Biol Med. 30, 1191-1212.

Schnell, R.; Borchmann, P.; Staak, J.O.; Schindler, J.; Ghetie, V.; Vitetta, E.S.; Engert, A.  (2003) Clinical evaluation of ricin A-chain immunotoxins in patients with Hodgkin's lymphoma.  Ann Oncol. 14, 729-736.

Schulze-Osthoff, K.; Bakker, A. C.; Vanhaesebroeck, B.; Beyaert, R.; Jacob, W. A.; Fiers, W. (1992)  Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation.   J. Biol. Chem. 267, 5317-5323.

Schulze-Osthoff, K.; Beyaert, R.; Vandevoorde, V.; Haegeman, G.; Fiers, W. (1993) Depletion of the mitochondrial electron transport abrogates the cytotoxic and gene-inductive effects of TNF.  EMBO J. 12, 3095-3104.

Schulze-Osthoff, K.; Ferrari, D.; Los, M.; Wesselborg, S.; Peter, M.E.  (1998).  Apoptosis signaling by death receptors.  Eur. J Biochem 254, 439-459.

Schulze-Osthoff, K.; Bakker, A.C.; Vanhaesebroeck, B.; Beyaert, R.; Jacob, W.A.; Fiers, W. (1992)  Cytotoxic activity of tumour necrosis factor is mediated by early damage of mitochondrial functions.  Evidence for the involvement of mitochondrial radical generation.  J Biol Chem 267, 5317-5323.

 

Shih, S.F.; Wu, Y.H.; Hung, C.H.; Yang, H.Y.; Lin, J.Y.  (2001) Abrin triggers cell death by inactivating a thiol-specific antioxidant protein.  J Biol Chem. 276, 21870-21877.

Sjogren, R.W.; Colleton, C.; Shea-Donohue, T.  (1994)  Intestinal myoelectric response in two different models of acute enteric inflammation.  Am J Physiol. 267, G329-37.

Sies, H. (1987). Antioxidant activity in cells and organs.  Am. Rev. Respir. Dis. 136, 478-480.

Simmons, B.M.; Stahl, P.D.; Russell, J.H. (1986)  Mannose receptor-mediated uptake of ricin toxin and ricin A chain by macrophages.  Multiple intracellular pathways for A chain translocation.  J Biol chem. 261, 7912-7920.

Skilleter, D.N.; Paine, A.J.; Stirpe, F. (1981) A comparison of the accumulation of ricin by hepatic parenchymal and non-parenchymal cells and its inhibition of protein synthesis.  Biochim Biophys Acta. 677, 495-500.

Smallshaw, J.E.; Firan, A.; Fulmer, J.R.; Riback, S.L.; Ghetie, V.; Vitetta, E.S.  (2002)  A novel recombinant vaccine which protects mice against ricin intoxication.  Vaccine 20, 3422-3427.

Soler-Rodriquez, A.; Ghetie, M.; Oppenheimer-Marks N.; Uhr, J.; Vitetta E.  (1993)  Ricin-A chain and ricin-A-chain immunotoxins rapidly damage human endothelial cells:  Implications for vascular leak syndrome.  Exp Cell Res 206, 227-234.

Stahl, P.; Gordon, S. (1982)  Expression of a mannosyl-fucosylreceptor for endocytosis on cultured primary macrophages and their hybrids.  J Cell Biol 93, 49-56.

Stein, M.; Keshav, S.; Harris, N.; Gordon, S. (1992)  Interleukin 4 potently enhances murine macrophage mannose receptor activity:  a marker of altyernative immunologic macrophage activation.  J Exp Med 176, 287-292.

Stohs, S. J.; Bagchi, D.  (1995)  Oxidative mechanisms in the toxicity of metal ions.  Free Radic Biol Med. 18, 321-336.

Stojadinovic, A.; Kiang, J.; Goldhill, J.; Matin, D.; Smallridg,e R.; Galloway, R.; Shea-Donohue, T. (1997) Induction of the heat shock response prevents tissue injury during acute inflammation of the rat ileum.Crit Care Med. 25, 309-317.

Stirpe, F. (2004) Ribosome-inactivating proteins.  Toxicon 44, 371-383.

Suntres, Z.E. (2002) Role of Antioxidants in Paraquat Toxicity.  Toxicol. 180, 65-77.

Suntres, Z.E.; Shek, P.N.  (1996)   The pulmonary uptake of intravenously administered liposomal a-tocopherol liposomes is augmented in acute lung injury.  J. Drug Target.  4, 151-159.

Suntres, Z.E.; Shek, P.N. (1998)  Prophylaxis of LPS-induced lung injury by  a-tocopherol liposomes.  Crit Care Med, 26, 723-729.

Tas, S.W.; Remans, P.H.; Reedquist, K.A.; Tak, P.P. (2005)  Signal transduction pathways and transcription factors as therapeutic targets in inflammatory disease: towards innovative antirheumatic therap Curr Pharm Des.11:581-611.. 

Tamura, T.; Sadakata, N.; Oda, T.; Muramatsu, T.  (2002).  Role of zinc ions in ricin-induced apoptosis in U937 cells.  Toxicol. Lett. 132, 141-151.

Thomas, E. L.; Grisham, M.B.; Jefferson, M.M.  (1983)   Myeloperoxidase-dependent effect of amines on functions of isolated neutrophils. J. Clin. Invest. 72, 441-454. 

Toyokuni, S.  (1999) Reactive oxygen species-induced molecular damage and its application in pathology.  Pathol Int. 49, 91-102.

Vandenabeele,P.; Declercq,W.; Beyaert,R.; Fiers,W. (1995) Two tumour necrosis factor receptors: structure and function. Trends Cell Biol. 5, 392–399.

Villa, P.; Kaufmann, S.H.; Earnshaw, W.C. (1997)  Caspases and caspase inhibitors.  TIBS Rev. 22, 388-393.

Winterbourn, C. C. (1985) Comparative reactivities of various biological compounds with myeloperoxidase-hydrogen peroxide-chloride, and similarity of the oxidant to hypochlorite. Biochim. Biophys. Acta 840, 204-210.

Winterbourn, C. C; van den Berg, J.J.M.; Roitman, E.; Kuypers, F.A.  (1992) Chlorohydrin formation from unsaturated fatty acids reacted with hypochlorous acid. Arch. Biochem. Biophys. 296, 547-555.

Wilhelmsen, C.L.; Pitt, M.L.  (1996)  Lesions of acute inhaled lethal ricin intoxication in rhesus monkeys.  Vet. Pathol. 33:296-302.

Williams, J.M.; Lote, C.J.; Thewles, A.; Wood, J.A.; Howie, A.J.; Williams, M.C.; Adu, D.A.; Taylor, C.M. (2000)   Role of nitric oxide in a toxin-induced model of haemolytic uraemic syndrome.  Pediatr Nephrol. 14, 1066-1070.

Xanthoudakis, S.; Miao, G.G.; Curran, T. (1994)  The redox and DNA-repair activities of Ref-1 are encoded by nonoverlapping domains. Proc Natl Acad Sci U S A 91: 23-27.        

Xu, L.L.; McVicar, D.W.; Ben-Baruch, A.; Kunhs, D.B.; Johnston, J.; Oppenheim, J.J.; Wang, J.M. (1995) Monocyte chemotactic protein-3 (MCP3) interacts with multiple leukocyte receptors: binding and signaling of MCP3 through shared as well as unique receptors on monocytes and neutrophils. Eur. J. Immunol. 25, 2612–2617.

Yamasaki, C.; Nishikawa, K.; Zeng, X.T.; Katayama, Y.; Natori, Y.; Komatsu, N.; Oda, T.; Natori, Y (2004).  Induction of cytokines by toxins that have an identical RNA N-glycosidase activity: Shiga toxin, ricin, and modeccin.  Biochim Biophys Acta. 1671,44-50.

Zafarullah, M.; Li, W.Q.; Sylvester, J.; Ahmad M., (2003) Molecular mechanisms of N-acetylcysteine actions.  Cell Mol Life Sci. 60, 6-20.

Zenilman, M.E.; Fiani, M.; Stahl, P.D.; Brunt, E.M.; Flye, M.W. (1988)  Use of ricin A-chain to selectively deplete Kupffer cells.  J Surg Res. 45, 82-89.

Zenilman, M.E.; Fiani, M.; Stahl, P.D.; Brunt, E.M.; Flye, M.W. (1989)  Selective depletion of Kupffer cells in mice by intact ricin.  Transplantation. 47, 200-203.

Zoratti, M.; Szabo, I. (1995) The mitochondrial permeability transition. Biochem. Biophys. Acta. 124, 139-176.